Skip to main content
. 2015 Apr 22;45(5):364–371. doi: 10.4070/kcj.2015.45.5.364

Table 2. Serum APE1/Ref-1 and clinical outcomes.

Total (n=354) Angina (n=128) MI (n=175) p
Total 35 (9.9) 12 (9.4) 23 (13.1)
Death 26 (7.3) 8 (6.3) 18 (10.3)
Recurrent MI 0 (0.0) 0 (0.0) 0 (0.0) Not significant
Stroke 1 (0.3) 0 (0.0) 1 (0.6)
Revascularization 8 (2.3) 4 (3.1) 4 (2.3)

Data are expressed as n (%). APE1/Ref-1: apurinic/apyrimidinic endonuclease 1/redox effector factor 1, MI: myocardial infarction